Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Cullinan Therapeutics, Inc. per 2025 Jun 30 adalah -234.70 MM.
- Nilai net income untuk Cullinan Therapeutics, Inc. per 2025 Jun 30 adalah -206.76 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -234.70 | -206.76 | |
2025-03-31 | -208.93 | -178.74 | |
2024-12-31 | -196.92 | -167.38 | |
2024-09-30 | -187.36 | -143.54 | |
2024-06-30 | -183.30 | -142.16 | |
2024-03-31 | -170.88 | -132.35 | |
2023-12-31 | -190.65 | -153.16 | |
2023-09-30 | -179.77 | -156.14 | |
2023-06-30 | -164.74 | -141.76 | |
2023-03-31 | -162.24 | 65.35 | |
2022-12-31 | -132.14 | 111.21 | |
2022-09-30 | 0.00 | -131.88 | 105.48 |
2022-06-30 | 0.00 | -120.48 | 112.94 |
2022-03-31 | 0.00 | -101.98 | -77.60 |
2021-12-31 | 18.94 | -67.95 | -65.57 |
2021-09-30 | 18.94 | -69.28 | -61.40 |
2021-06-30 | 18.94 | -62.40 | -53.91 |
2021-03-31 | 18.94 | -53.42 | -46.90 |
2020-12-31 | -60.34 | -51.80 | |
2020-09-30 | -29.64 | -28.02 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | -3.10 | -3.10 |
2024-12-31 | -3.11 | |
2024-09-30 | -2.88 | -2.88 |
2024-06-30 | -3.10 | -3.10 |
2024-03-31 | -3.14 | -3.14 |
2023-12-31 | -3.69 | |
2023-09-30 | -3.69 | -3.69 |
2023-06-30 | -3.30 | -3.30 |
2023-03-31 | 1.48 | 1.43 |
2022-12-31 | 2.46 | 2.38 |
2022-09-30 | 2.38 | 2.31 |
2022-06-30 | 2.56 | 2.52 |
2022-03-31 | -1.78 | -1.77 |
2021-12-31 | -1.52 | -1.52 |
2021-09-30 | -1.22 | -1.22 |
2021-06-30 | -1.35 | -1.35 |
2021-03-31 | -1.58 | -1.58 |
2020-12-31 | -2.60 | |
2020-09-30 | -11.97 | -11.97 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Cullinan Therapeutics, Inc. per 2025 Jun 30 adalah -171.53 MM.
- Nilai cash from investing activities untuk Cullinan Therapeutics, Inc. per 2025 Jun 30 adalah 126.05 MM.
- Nilai kas dari aktivitas pendanaan untuk Cullinan Therapeutics, Inc. per 2025 Jun 30 adalah 3.28 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -171.53 | 126.05 | 3.28 |
2025-03-31 | -150.21 | -112.47 | 265.10 |
2024-12-31 | -145.30 | -136.31 | 266.19 |
2024-09-30 | -126.81 | -100.81 | 264.85 |
2024-06-30 | -126.81 | -163.64 | 263.64 |
2024-03-31 | -121.53 | 33.58 | 40.05 |
2023-12-31 | -134.28 | 35.81 | 40.75 |
2023-09-30 | -141.13 | -44.27 | 7.59 |
2023-06-30 | -161.34 | -59.29 | 8.90 |
2023-03-31 | -155.75 | 229.45 | -27.68 |
2022-12-31 | -126.66 | 248.97 | -25.93 |
2022-09-30 | -116.85 | 261.72 | 9.68 |
2022-06-30 | -73.05 | 294.11 | 8.84 |
2022-03-31 | -63.83 | -161.34 | 7.75 |
2021-12-31 | -43.43 | -333.77 | 268.78 |
2021-09-30 | -37.70 | -306.47 | 390.98 |
2021-06-30 | -36.22 | -282.82 | 391.61 |
2021-03-31 | -26.27 | -116.26 | 390.68 |
2020-12-31 | -29.77 | -5.42 | 140.14 |
2020-09-30 | -25.20 | -52.24 | 99.16 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/e untuk Cullinan Therapeutics, Inc. pada 2025 Jun 30 adalah -2.47.
- p/libro untuk Cullinan Therapeutics, Inc. pada 2025 Jun 30 adalah 0.80.
- p/tbv untuk Cullinan Therapeutics, Inc. pada 2025 Jun 30 adalah 0.80.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -2.47 | 0.80 | 0.80 |
2025-03-31 | 0.79 | 0.79 | |
2024-12-31 | 1.13 | 1.13 | |
2024-09-30 | -7.01 | 1.52 | 1.52 |
2024-06-30 | -7.44 | 2.31 | 2.31 |
2024-03-31 | -4.79 | 1.62 | 1.62 |
2023-12-31 | -2.79 | 0.93 | 0.93 |
2023-09-30 | -2.73 | 0.77 | 0.77 |
2023-06-30 | 6.77 | 0.91 | 0.91 |
2023-03-31 | 3.62 | 0.75 | |
2022-12-31 | 0.82 | 0.82 | |
2022-09-30 | 0.97 | 0.97 | |
2022-06-30 | -7.39 | 1.37 | 1.37 |
2022-03-31 | -7.10 | 1.09 | 1.09 |
2021-12-31 | -10.98 | 1.51 | 1.51 |
2021-09-30 | -18.26 | 2.15 | 2.15 |
2021-06-30 | |||
2021-03-31 | -9.57 | 0.96 | 0.96 |
2020-12-31 | |||
2020-09-30 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Cullinan Therapeutics, Inc. pada 2025 Jun 30 adalah 1.42.
- EBIT (3 tahun) / EV untuk Cullinan Therapeutics, Inc. pada 2025 Jun 30 adalah 1.29.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | 1.42 | 1.29 |
2025-03-31 | -0.43 | -0.16 |
2024-12-31 | -2.24 | -0.83 |
2024-09-30 | -0.18 | -0.06 |
2024-06-30 | -0.16 | -0.05 |
2024-03-31 | -0.27 | -0.04 |
2023-12-31 | -0.42 | -0.07 |
2023-09-30 | 1.19 | 0.13 |
2023-06-30 | 0.39 | 0.23 |
2023-03-31 | 0.61 | -0.00 |
2022-12-31 | -1.18 | -0.13 |
2022-09-30 | -2.22 | -0.28 |
2022-06-30 | -0.61 | -0.38 |
2022-03-31 | -1.94 | -1.36 |
2021-12-31 | -0.11 | -0.08 |
2021-09-30 | -0.06 | -0.03 |
2021-06-30 | ||
2021-03-31 | -0.12 | -0.07 |
2020-12-31 | ||
2020-09-30 |
Efektivitas Manajemen
- roa untuk Cullinan Therapeutics, Inc. pada 2025 Jun 30 adalah -0.26.
- roe untuk Cullinan Therapeutics, Inc. pada 2025 Jun 30 adalah -0.27.
- roic untuk Cullinan Therapeutics, Inc. pada 2025 Jun 30 adalah -0.32.
- croic untuk Cullinan Therapeutics, Inc. pada 2025 Jun 30 adalah 0.00.
- ocroic untuk Cullinan Therapeutics, Inc. pada 2025 Jun 30 adalah -0.27.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.26 | -0.27 | -0.32 | 0.00 | -0.27 |
2025-03-31 | -0.37 | -0.39 | -0.28 | -0.03 | -0.25 |
2024-12-31 | -0.30 | -0.32 | -0.23 | 0.06 | -0.20 |
2024-09-30 | -0.29 | -0.30 | -0.22 | -0.04 | -0.19 |
2024-06-30 | -0.26 | -0.27 | -0.31 | -0.11 | -0.28 |
2024-03-31 | -0.27 | -0.29 | -0.33 | -0.13 | -0.29 |
2023-12-31 | -0.25 | -0.27 | -0.33 | -0.37 | -0.30 |
2023-09-30 | -0.21 | -0.23 | -0.28 | -0.42 | -0.32 |
2023-06-30 | 0.10 | 0.11 | -0.28 | -0.42 | -0.32 |
2023-03-31 | 0.25 | 0.27 | 0.13 | 0.09 | -0.32 |
2022-12-31 | 0.23 | 0.24 | 0.18 | 0.26 | -0.20 |
2022-09-30 | 0.25 | 0.25 | 0.18 | 0.26 | -0.20 |
2022-06-30 | -0.17 | -0.17 | 0.19 | 0.38 | -0.12 |
2022-03-31 | -0.14 | -0.14 | -0.18 | -0.52 | -0.15 |
2021-12-31 | -0.29 | -0.31 | -0.15 | -0.25 | -0.08 |
2021-09-30 | -0.63 | -0.60 | -0.14 | 0.11 | -0.08 |
2021-06-30 | -0.51 | -0.54 | -0.12 | 0.16 | -0.08 |
2021-03-31 | -0.47 | -0.48 | -0.10 | 0.53 | -0.06 |
2020-12-31 | -0.52 | -0.53 | -0.26 | 0.52 | -0.15 |
2020-09-30 | -0.84 | -0.31 | 0.24 | -0.28 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | 1.00 | ||
2021-12-31 | 1.00 | -3.46 | -3.59 |
2021-09-30 | 1.00 | -3.24 | -3.31 |
2021-06-30 | 1.00 | -2.85 | -3.29 |
2021-03-31 | 1.00 | -2.48 | -2.82 |
2020-12-31 | |||
2020-09-30 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1789972 |
Grupong Pang-industriya
SIC 2836 - Biological Products, Except Diagnostic Substances (Biotech) |